West Pharmaceutical Services Overview
Latest P/E ratio for West Pharmaceutical Services: 43.32 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow43.32
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
West Pharmaceutical Services (WST) currently reports a P/E ratio of 43.32. That is above the Healthcare sector average of 27.42. Use the charts on this page to explore West Pharmaceutical Services's P/E ratio history and peer comparisons.
West Pharmaceutical Services's P/E ratio of 43.32 is higher than the Healthcare sector average of 27.42. That is roughly 58.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates West Pharmaceutical Services's market price to a fundamental measure such as earnings, sales, or book value. At 43.32, WST can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 43.32, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.42. From there, open related valuation or income-statement pages for West Pharmaceutical Services, and consider following WST for alerts when major investors trade the stock.
West Pharmaceutical Services is classified in the Healthcare sector. On P/E ratio, it currently shows 43.32 versus a sector average near 27.42. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WST with unrelated industries.
